Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 12 (1), 11-26

Emerging Biomarkers in Head and Neck Cancer in the Era of Genomics


Emerging Biomarkers in Head and Neck Cancer in the Era of Genomics

Hyunseok Kang et al. Nat Rev Clin Oncol.


Head and neck cancer (HNC) broadly includes carcinomas arising from the mucosal epithelia of the head and neck region as well as various cell types of salivary glands and the thyroid. As reflected by the multiple sites and histologies of HNC, the molecular characteristics and clinical outcomes of this disease vary widely. In this Review, we focus on established and emerging biomarkers that are most relevant to nasopharyngeal carcinoma and head and neck squamous-cell carcinoma (HNSCC), which includes primary sites in the oral cavity, oropharynx, hypopharynx and larynx. Applications and limitations of currently established biomarkers are discussed along with examples of successful biomarker development. For emerging biomarkers, preclinical or retrospective data are also described in the context of recently completed comprehensive molecular analyses of HNSCC, which provide a broad genetic landscape and molecular classification beyond histology and clinical characteristics. We will highlight the ongoing effort that will see a shift from prognostic to predictive biomarker development in HNC with the goal of delivering individualized cancer therapy.

Similar articles

See all similar articles

Cited by 80 PubMed Central articles

See all "Cited by" articles


    1. Cancer Cell. 2011 Jan 18;19(1):101-13 - PubMed
    1. N Engl J Med. 2009 Sep 3;361(10):958-67 - PubMed
    1. Lancet Oncol. 2013 Mar;14(3):257-64 - PubMed
    1. Clin Cancer Res. 2006 Sep 1;12(17):5064-73 - PubMed
    1. Br J Cancer. 2013 Oct 15;109 (8):2248-58 - PubMed

MeSH terms